The current valuation score of Abcellera Biologics Inc is 7.59, ranking 158 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -11.91, which is -268.76% below the recent high of 20.10 and -259.82% above the recent low of -42.86.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.